Ocular changes in patients undergoing long-term desferrioxamine treatment.
Open Access
- 1 December 1984
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 68 (12) , 873-877
- https://doi.org/10.1136/bjo.68.12.873
Abstract
In a group of young patients with thalassaemia and iron overload treated by subcutaneous infusions of desferrioxamine we have found a number of minor alterations in retinal function. The incidence of such changes is not related to drug dosage or to ferritin level but to abnormality of the extended glucose tolerance test.This publication has 17 references indexed in Scilit:
- DESFERRIOXAMINE, OCULAR TOXICITY, AND TRACE METALSThe Lancet, 1983
- An automated statis perimeter/adaptometer using light emitting diodes.British Journal of Ophthalmology, 1983
- Retinal Abnormalities Associated With AnemiaArchives of Ophthalmology (1950), 1983
- OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINEThe Lancet, 1983
- A modified ERG technique and the results obtained in X-linked retinitis pigmentosa.British Journal of Ophthalmology, 1983
- IMPROVEMENT IN IRON STATUS AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1979
- PREVENTION OF IRON LOADING IN TRANSFUSION-DEPENDENT THALASSÆMIAThe Lancet, 1978
- DIALYSIS ANÆMIA CAUSED BY SUBACUTE ZINC TOXICITYThe Lancet, 1977
- An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overloadJournal of Clinical Pathology, 1972
- NEW CLINICAL TEST OF RETINAL FUNCTION BASED UPON THE STANDING POTENTIAL OF THE EYEBritish Journal of Ophthalmology, 1962